Cargando…
Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand
OBJECTIVE: To determine if a human bladder cancer-specific peptide named PLZ4 can target canine bladder cancer cells. EXPERIMENTAL DESIGN: The binding of PLZ4 to five established canine invasive transitional cell carcinoma (TCC) cell lines and to normal canine bladder urothelial cells was determined...
Autores principales: | Lin, Tzu-yin, Zhang, Hongyong, Wang, Sisi, Xie, Li, Li, Bin, Rodriguez, Carlos O, de Vere White, Ralph, Pan, Chong-xian |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3040722/ https://www.ncbi.nlm.nih.gov/pubmed/21272294 http://dx.doi.org/10.1186/1476-4598-10-9 |
Ejemplares similares
-
Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer
por: Lin, Tzu-yin, et al.
Publicado: (2012) -
Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer
por: Wang, Sisi, et al.
Publicado: (2016) -
Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
por: Pan, Chong-xian, et al.
Publicado: (2015) -
Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells
por: Gheibi, Pantea, et al.
Publicado: (2017) -
Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice
por: Martin, Kelly A., et al.
Publicado: (2019)